Last update:

Weight management news

At 'most favored nation' prices, can Medicare break even on GLP-1 drugs?

In November 2025, the White House announced pricing deals with multiple pharmaceutical manufacturers to lower domestic prices for glucagon-like peptide-1 receptor agonist drugs (GLP-1RAs) including Ozempic, Wegovy, Mounjaro, ...

Wealth and health divide: Obesity rates plateau in rich nations but surge in developing world

Obesity has long been the invisible health crisis looming over humanity, with rates climbing globally. There is some positive news now emerging from a multi-decade study spanning several nations. A recent study published ...

Stronger regulation needed to address injectable peptide craze

Tougher regulation on peptide supplies is needed as illegal use skyrockets among young Australians, University of Queensland researchers say. Dr. Timothy Piatkowski, of UQ's School of Public Health, said the country's regulatory ...

How understanding art history can help doctors treat obesity

Understanding how obesity has been portrayed in art across the ages can make doctors more empathetic and less judgmental, which should lead to their patients achieving better outcomes, new research at the European Congress ...